IMIPRAMINE-PROMAZINE THERAPY FOR DEPRESSION
Abstract
Imipramine-promazine therapy resulted in an overall good clinical response in 80% of a group of patients with depressive syndromes. Response of symptoms of anxiety alone was over 90%. Patients were treated privately, and received intensive psychotherapy which included other members of the family. Most patients were very comfortable on the mixture. Serious side effects were few and blood pressure changes were minimal. Additional dosage of phenothiazine was necessary in some cases, especially at night, to induce sleep. The Imipramine-promazine combination appears to be highly effective, and would seem to be particularly useful in this new capsule form for the general practitioner and in outpatient clinics.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
